Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2005
11/03/2005US20050245509 Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
11/03/2005US20050245493 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244965 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244903 Diagnostic and examination method for eating disorder
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244515 Anti-microbial agent and anti-microbial composition
11/03/2005US20050244507 For treatment of organ or tissue hypertrophy; inducible in post-oestrus sheep by clomiphene
11/03/2005US20050244438 Simple and multiple emulsions for decontamination of an organism or surfaces
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050244358 Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2561073A1 Composition and method for cancer treatment
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1591135A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591127A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1591117A1 Breast cancer resistance protein (bcrp) inhibitor
11/02/2005EP1591116A1 Inhibitor for perioperative blood sugar elevation
11/02/2005EP1591115A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/02/2005EP1591112A1 Breast cancer-resistant protein inhibitor
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1472256B1 Piperidine derivatives
11/02/2005EP1425007B1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1292304B1 Zolpidem hemitartrate
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1200320B1 Valve with a two-component seal
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP1005488B1 Receptor that binds trail
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005EP0738152B1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1692161A Treatment for asthma or allergies
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692116A Adenosine A2A receptor antagonists
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692110A New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1691960A Inhibitors for continuous activation of calcineurin
11/02/2005CN1691959A Interleukin 6 production inhibitor
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691943A Cancer treatment with go6976 and its related compounds
11/02/2005CN1691941A Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
11/02/2005CN1689560A Agents for fattening animals
11/02/2005CN1689431A Beverage for fattening animals
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225466C Sodium-hydrogen exchanger type 1 inhibitor (NHE-1)
11/02/2005CN1225465C Novel compounds
11/02/2005CN1225462C New piperazine and piperidine compounds
11/02/2005CN1225278C Nutrient healthy powder for delaying senescence
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/02/2005CN1225233C Aqueous composition for bleaching keratin fibers instantaneously
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960678 Silanol enzyme inhibitors
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960661 [7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein
11/01/2005US6960646 Cyclic peptides as potent and selective melanocortin-4 receptors agonists
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960608 Fused indazoles and indoles and their use for the treatment of glaucoma
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960592 erectile dysfunction; halosulfonation of 2-ethoxy benzoic acid, sulfonamidation, haloacylation, deacylation and amidation, cyclization; phosphodiesterase inhibitor; side-effect reduction; long lasting
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 1564